AusPAR: Golimumab (rmc)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

11 October 2013
AusPAR Details
AusPAR
Active Ingredient
Golimumab (rmc)
Product Name
Simponi and Simponi Smartject Injector
Sponsor
Janssen-Cilag Pty Ltd
Submission Number
PM-2012-01202-3-3
Submission Type
Extension of indications, Changes to Product Information
Decision
Approved
AusPAR Date
16 August 2013
Publication Date

11 October 2013